K. Ejeskär

发表

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours

H. Carén, C. Krona, T. Martinsson, 2004, British Journal of Cancer.

Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours

C. Krona, T. Martinsson, R. Sjöberg, 2002, British Journal of Cancer.

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation

L. Hesson, H. Carén, F. Latif, 2005, Molecular Cancer.

The Effects of Probiotics on High Sugar-Induced Type 2 Diabetes Mellitus Symptoms in Drosophila melanogaster

K. Ejeskär, F. Szekeres, 2019 .

DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma

Hendrik A. de Weerd, K. Ejeskär, Simon Keane, 2022, DNA Repair.

DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma.

K. Ejeskär, Simon Keane, H. D. de Weerd, 2021, DNA repair.

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

P. Kogner, T. Martinsson, K. Ejeskär, 2020, Cancer cell international.

Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival

K. Ejeskär, Angelica Lindlöf, Simon Keane, 2020, Cell Communication and Signaling.

Inflammation suppresses DLG2 expression decreasing inflammasome formation

Y. Wettergren, K. Ejeskär, P. Rolny, 2022, Journal of Cancer Research and Clinical Oncology.

Drosophila model of myosin myopathy rescued by overexpression of a TRIM-protein family member

R. Palmer, A. Uv, M. Olivé, 2018, Proceedings of the National Academy of Sciences.

Variable skeletal phenotypes associated with biallelic variants in PRKG2

A. Pagnamenta, Matteo P. Ferla, Jenny C. Taylor, 2021, Journal of Medical Genetics.

Inflammation suppresses DLG2 expression decreasing inflammasome formation

Y. Wettergren, K. Ejeskär, P. Rolny, 2022, Journal of Cancer Research and Clinical Oncology.

Na+/K+‑ATPase subunit α3 expression is associated with the efficacy of digitoxin treatment in pancreatic cancer cells

K. Ejeskär, F. Szekeres, H. Lindholm, 2022, Medicine international.

Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype

K. Ejeskär, F. Szekeres, H. Lindholm, 2022, International journal of molecular sciences.

Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric Glioma

T. O. Bontell, H. Carén, M. Tisell, 2022, Cancer Genomics & Proteomics.

Bioinformatics analysis of miRNAs in the neuroblastoma 11q-deleted region reveals a role of miR-548l in both 11q-deleted and MYCN amplified tumour cells

Zelmina Lubovac-Pilav, K. Ejeskär, Emmy Borgmästars, 2022, Scientific Reports.

Impaired muscle morphology in a Drosophila model of myosin storage myopathy was supressed by overexpression of an E3 ubiquitin ligase

M. Olivé, K. Ejeskär, M. Pokrzywa, 2020, Disease Models & Mechanisms.

EFFECTS OF 25-HYDROXYVITAMIN D3 AND DIGITOXIN IN PROSTATE CANCER CELLS

K. Ejeskär, 2017 .

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib

I. Øra, M. Tisell, J. Nilsson, 2021, Cancer biology & therapy.

Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2

Tommy Martinsson, T. Martinsson, K. Ejeskär, 2007, Genes, chromosomes & cancer.

Verification of microRNA expression in human endometrial adenocarcinoma

K. Klinga-Levan, K. Ejeskär, Sanja Jurcevic, 2016, BMC Cancer.

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.

Per Kogner, Tommy Martinsson, P. Kogner, 2013, International journal of oncology.

p110α Hot Spot Mutations E545K and H1047R Exert Metabolic Reprogramming Independently of p110α Kinase Activity

J. Borén, Y. Wettergren, L. Akyürek, 2015, Molecular and Cellular Biology.

The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo

A. Uv, Y. Wettergren, K. Ejeskär, 2015, PloS one.

p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors

M. Bergo, A. Uv, Y. Wettergren, 2012, Oncogene.

Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT

J. Marcickiewicz, B. Olsson, M. Hörnquist, 2016, PloS one.

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24

P. Kogner, T. Martinsson, F. Abel, 1999, British Journal of Cancer.

Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity

C. Kahn, Y. Wettergren, K. Ejeskär, 2017, F1000Research.

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours

H. Carén, P. Kogner, T. Martinsson, 2007, British Journal of Cancer.

Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death

F. Zaibak, H. Carén, P. Ioannou, 2005, BMC Cancer.

MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression

E. Kristiansson, S. Nilsson, A. Muth, 2020, PLoS genetics.

Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity.

C. Kahn, Y. Wettergren, K. Ejeskär, 2017, F1000Research.

High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival

K. Ejeskär, S. Fransson, 2013, Medical Oncology.

Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2

P. Kogner, C. Krona, T. Martinsson, 2003, Oncogene.

Verification of microRNA expression in human endometrial adenocarcinoma

K. Klinga-Levan, B. Olsson, K. Ejeskär, 2016, BMC Cancer.

Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.

P. Ambros, P. Kogner, T. Martinsson, 2001, Medical and pediatric oncology.

Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors

P. Kogner, T. Martinsson, R. Sjöberg, 2000, Cytogenetic and Genome Research.

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas

P. Kogner, T. Martinsson, K. Ejeskär, 2013, Journal of molecular signaling.

Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development.

P. Kogner, T. Martinsson, R. Sjöberg, 1999, International journal of molecular medicine.

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.

H. Aburatani, J. Abrahamsson, P. Kogner, 1998, British Journal of Cancer.

Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders

J. Lupski, S. Lalani, Matteo P. Ferla, 2023, Brain : a journal of neurology.

Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity [version 2; peer review: 2 approved, 1 approved with reservations]

C. Kahn, Y. Wettergren, K. Ejeskär, 2021 .